Membership Update – September 2012

BioNJ welcomes Enzon Pharmaceuticals back to BioNJ as a Core Member for 2012.

Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc., is a biotechnology company dedicated to the research and development of innovative therapeutics for patients with high unmet medical needs. Enzon’s drug-development programs utilize two platforms — Customized PEGylation Linker Technology (Customized Linker Technology®) and third-generation messenger RNA (mRNA)-targeting agents utilizing the Locked Nucleic Acid (LNA) technology. Enzon currently has four compounds in human clinical development and multiple novel mRNA antagonists in preclinical research. Enzon receives royalty revenues from licensing arrangements with other companies related to sales of products developed using its proprietary Customized Linker Technology.

 

BioNJ welcomes Medix Staffing Solutions and William H. Connolly & Co. as new Associate Members for 2012.

Medix Staffing Solutions
Medix Staffing Solutions’ Life Sciences division recruits the most seasoned talent in a wide range of healthcare, science, and laboratory-related organizations. Medix’s Life Science, Laboratory, and Quality Assurance sector has experience recruiting in many industries, including food and beverage, pharmaceutical, biotechnology, medical device, oil and gas, and environmental sciences. Within these industries, we place myriad professionals, such as chemists, biologists, and lab techs, in a variety of settings, including QA/QC laboratories, research and development, and regulatory. Additionally, Medix’s staffing verticals include placing professionals within the Professional Services and Information Technology industries as well.

William H. Connolly & Co., LLC
William H. Connolly & Co., LLC, serves the insurance and risk-management needs of a large and diverse group of businesses: biotechnology, healthcare, pharmaceutical, social service organizations, professional services, and individuals. Our reputation for excellence and integrity and our ability to meet our clients’ evolving needs drives our success. Aggressive and innovative in our pursuit of solutions to insurance and risk-management challenges, William H. Connolly & Co., LLC, is widely recognized for our expertise.

 

BioNJ thanks GE Healthcare, Joulé Clinical and Scientific Staffing Solutions, and LifeCell Corporation for renewing as Platinum Members for 2012.

GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, and treat disease, so their patients can live their lives to the fullest.

GE Healthcare’s broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new “early health” model of care focused on earlier diagnosis, pre-symptomatic disease detection, and disease prevention.

Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE:GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

Joulé Clinical and Scientific Staffing Solutions
For over 35 years, the Scientific Division of Joulé Clinical and Scientific Staffing Solutions has built a reputation of being the preeminent provider of scientific and clinical personnel in New Jersey, New York, and Pennsylvania. We are committed to providing logical staffing solutions by thoroughly understanding our clients’ needs and attracting a dynamic and intelligent applicant base to best meet those needs. This successful approach has made Joulé Clinical and Scientific Staffing Solutions the preferred staffing partner of many companies in the pharmaceutical, biotechnology, clinical research, consumer products, and specialty chemical industries.

LifeCell Corporation
LifeCell develops and markets innovative biologically based products in the emerging field of regenerative medicine for use in reconstructive, orthopedic, and urogynecologic surgical procedures.

 

BioNJ thanks Cancer Genetics, Celator Pharmaceuticals, PCAsso Diagnostics, and Vicus Therapeutics for renewing as Core Members for 2012.

Cancer Genetics, Inc.
Cancer Genetics, Inc. (CGI), is an emerging leader in the field of personalized medicine, offering products and services that enable cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual. Products and services being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs.

CGI’s cutting-edge proprietary tests and state-of-the-art reference laboratory provide critical genomic information where patients and their physicians need it most — to diagnose, monitor and inform cancer treatment.

CGI is committed to maintaining the standard of clinical excellence through its investment in outstanding facilities and equipment. Our reference laboratory is both CLIA certified and CAP accredited. In addition, we have approvals and accreditations from the states of Florida, Maryland, New York, and New Jersey.

Founded in 1999 by world-renowned cytogeneticist Dr. R.S.K. Chaganti, CGI’s scientific advisory board includes leading specialists in clinical cytogenetics, as well as significant thought leaders capable of driving adoption in the tri-state area. The company has been built on a foundation of world-class scientific knowledge and IP in solid and blood-borne cancers, as well as strong academic relationships with major cancer centers, such as Memorial Sloan-Kettering and the National Cancer Institute.

CGI is focused on delivering products and services that drive the highest levels of patient value. To achieve this, we have developed a corporate culture that inspires innovation, respects knowledge and fosters leadership. CGI’s dedicated staff takes pride in our specialized laboratory services, superior turnaround time (TAT), enhanced reporting, EMR integration, and ongoing research and development for new tests.

CGI’s full-service cancer genetic practice and path to innovation with research makes for optimal patient care management.

Celator Pharmaceuticals
Celator Pharmaceuticals is an oncology-focused, clinical development stage company with products developed based on proprietary technology for identifying synergistic drug ratios, fixing the desired ratio in a drug delivery vehicle in order to maintain the ratio in patients and improve clinical outcomes.

PCAsso Diagnostics, LLC
PCAsso Diagnostics is a research and development company committed to the identification and development of novel medical diagnostic technologies. We are currently developing PolyChromatic Angiography (PCA), a new diagnostic tool with color capability for the quantitative assessment of vascular leakage in diseases of the retina that we expect to be a best-in-class/next-generation product. The same proprietary concept of PCA can be used, with modifications, to diagnose diseases in other organ systems, including the kidney and the brain, as well as malignant solid tumors.

Vicus Therapeutics
Vicus Therapeutics is a private biopharmaceutical company dedicated to bringing breakthrough multi-drug treatments to patients with cancer. Vicus focuses on identifying drugs that have already gained FDA approval for non-cancer indications and have completed initial clinical testing for the treatment of cancer-related indications. Vicus partners with pharmaceutical companies and then develops these drugs as components of multi-drug treatment regimens that can enhance the effectiveness of the partners’ FDA-approved targeted oncology drug products.
Because all the components of the multi-drug regimens are already FDA-approved, patients can gain access to the new treatments as soon as positive clinical results are published.

 

BioNJ thanks Cornerstone Search Group, J. H. Cohn and Silicon Valley Bank for renewing as Associate Members for 2012.

Cornerstone Search Group
Cornerstone Search Group is a specialized pharmaceutical/biotechnology executive search and recruitment firm located in the heart of New Jersey’s biotechnology and pharmaceutical corridor. Cornerstone Search Group helps its pharmaceutical and biotechnology clients identify, attract, and hire accomplished professionals from the experienced staff levels through the senior leadership ranks who are involved with the discovery, development, and commercialization of drugs/therapeutic treatments for the US and international markets.

Cornerstone Search Group’s team of highly experienced pharmaceutical and biotechnology specialty consultants/recruiters are adept at using their industry knowledge and contacts to generate desired results for their clients and candidates.

Since 2001, Pharmaceutical Advisors has offered an innovative approach to accessing a broad and deep network of expertise to support our clients’ drug development, commercialization, technology, and opportunity assessment needs. We help clients moving from discovery to development as well as clients with commercial products but more projects than they can resource, helping them to progress while navigating the challenges of outsourcing to CMOs and CROs. We help management and investors better understand risk and value. Our approach to assembling expert teams helps suppliers better understand their customers’ needs and how to serve them. We address technical issues, help manage programs, as well as support strategy and portfolio management. Our approach provides unique and customized product development planning, implementation and issue resolution, technical, operational, and “manufacturability” due diligence, strategy and operational improvement, market opportunity assessment, valuation and commercialization support for clients in various life sciences industries.

J. H. Cohn LLP
J. H. Cohn LLP is one of the top 15 accounting and business consulting firms in the United States. Since 1919, the firm’s philosophy has been to provide a personalized approach to each client, with intelligent guidance and solutions. The Technology and Life Sciences Industry Group helps biotechnology firms develop quality financial packages, implement strong financial controls, and achieve their financial objectives. Visit our website.

Silicon Valley Bank
For 25 years, Silicon Valley Bank has been dedicated to providing global financial services to some of the most innovative and entrepreneurial companies in the technology, life science, private equity, and premium wine industries. Our experience with these industries affords us a deep understanding of our clients’ business models and a high level of comfort with the business cycles inherent to these dynamic markets.

 

BioNJ thanks We Work for Health for renewing as an Institutional Member for 2012.

We Work for Health
We Work for Health brings together leaders in research, medicine, public health, academia, education, labor, and business to raise awareness of the importance of preserving medical innovation. This unique network seeks to demonstrate to federal policymakers, key opinion leaders and the media the need for strong public policy to promote innovation and, along with it, the health of Americans and the economy.